These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 30338683)

  • 1. Triple therapy: worth the risk?
    Wernly B; Lichtenauer M; Hoppe UC; Lauten A; Navarese EP; Jung C
    Minerva Med; 2018 Oct; 109(5):403-405. PubMed ID: 30338683
    [No Abstract]   [Full Text] [Related]  

  • 2. Edoxaban versus placebo, aspirin, or aspirin plus clopidogrel for stroke prevention in atrial fibrillation. An indirect comparison analysis.
    Blann AD; Skjøth F; Rasmussen LH; Larsen TB; Lip GY
    Thromb Haemost; 2015 Aug; 114(2):403-9. PubMed ID: 26062437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The CHAMPION PHOENIX study].
    Musumeci G; Limbruno U
    G Ital Cardiol (Rome); 2013 Oct; 14(10):641-6. PubMed ID: 24121887
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship between activated clotting time and ischemic or hemorrhagic complications: analysis of 4 recent randomized clinical trials of percutaneous coronary intervention.
    Brener SJ; Moliterno DJ; Lincoff AM; Steinhubl SR; Wolski KE; Topol EJ
    Circulation; 2004 Aug; 110(8):994-8. PubMed ID: 15302778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term antiplatelet therapy following myocardial infarction: implications of PEGASUS-TIMI 54.
    Parker WA; Storey RF
    Heart; 2016 May; 102(10):783-9. PubMed ID: 26857211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fighting residual cardiovascular risk in stable patients with atherosclerotic vascular disease: COMPASS in context.
    Patrono C
    Cardiovasc Res; 2017 Dec; 113(14):e61-e63. PubMed ID: 29186439
    [No Abstract]   [Full Text] [Related]  

  • 7. A randomized trial to compare the safety of rivaroxaban vs aspirin in addition to either clopidogrel or ticagrelor in acute coronary syndrome: The design of the GEMINI-ACS-1 phase II study.
    Povsic TJ; Roe MT; Ohman EM; Steg PG; James S; Plotnikov A; Mundl H; Welsh R; Bode C; Gibson CM
    Am Heart J; 2016 Apr; 174():120-8. PubMed ID: 26995378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing the Safe Use of Direct Oral Anticoagulants in Older Patients: A Teachable Moment.
    Sennesael AL; Dogné JM; Spinewine A
    JAMA Intern Med; 2015 Oct; 175(10):1608-9. PubMed ID: 26237648
    [No Abstract]   [Full Text] [Related]  

  • 9. ["Triple therapy" with warfarin, clopidogrel and acetylsalicylic acid. High risk treatment with unclear benefit].
    Wallén H; Agren A; Nekludov M
    Lakartidningen; 2007 Nov 28-Dec 4; 104(48):3640-2. PubMed ID: 18193674
    [No Abstract]   [Full Text] [Related]  

  • 10. Rivaroxaban (Xarelto) plus aspirin for secondary prevention of cardiovascular events.
    Med Lett Drugs Ther; 2018 Dec; 60(1561):196-197. PubMed ID: 30653475
    [No Abstract]   [Full Text] [Related]  

  • 11. Dual antiplatelet therapy for coronary stenting: a clear path for a research agenda.
    Leopold JA; Antman EM
    Circulation; 2005 Mar; 111(9):1097-9. PubMed ID: 15753225
    [No Abstract]   [Full Text] [Related]  

  • 12. [Safety of aspirin, clopidogrel, and acenocumarol combination in patients requiring anticoagulation].
    Sánchez-Torrijos J; Gudín-Uriel M; Ridocci-Soriano F
    Rev Esp Cardiol; 2006 Dec; 59(12):1345-6. PubMed ID: 17194433
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clopidogrel as basic therapy in high-risk stroke patients].
    Mattle HP
    Praxis (Bern 1994); 2004 Aug; 93(34):1364. PubMed ID: 15468694
    [No Abstract]   [Full Text] [Related]  

  • 14. [Triple therapy for patients with stent and atrial fibrillation? Yes!].
    Gulba DC
    Dtsch Med Wochenschr; 2013 Sep; 138(39):1966. PubMed ID: 24046139
    [No Abstract]   [Full Text] [Related]  

  • 15. Stroke: advances in therapy.
    Schellinger PD; Hacke W
    Lancet Neurol; 2005 Jan; 4(1):2. PubMed ID: 15620844
    [No Abstract]   [Full Text] [Related]  

  • 16. Triple therapy: triple safety or triple danger?
    Dewilde W; Breet N; Ten Berg J
    Am J Cardiol; 2010 Feb; 105(4):579. PubMed ID: 20152257
    [No Abstract]   [Full Text] [Related]  

  • 17. Triple antithrombotic therapy with aspirin, a thienopyridine derivative plus oral anticoagulation in patients with atrial fibrillation undergoing coronary stenting.
    Pipilis A; Lazaros G; Tsakonas G; Stefanadis C
    Hellenic J Cardiol; 2010; 51(4):330-7. PubMed ID: 20650831
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comment about patients with dual antiplatelet therapy].
    García-Bracamonte B; Vanaclocha F
    Actas Dermosifiliogr; 2010 Mar; 101(2):194-5. PubMed ID: 20223172
    [No Abstract]   [Full Text] [Related]  

  • 19. Meta-analysis of trials comparing oral anticoagulation and aspirin versus dual antiplatelet therapy after coronary stenting. Clues for the management of patients with an indication for long-term anticoagulation undergoing coronary stenting.
    Rubboli A; Milandri M; Castelvetri C; Cosmi B
    Cardiology; 2005; 104(2):101-6. PubMed ID: 16020950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comment: Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?
    Friesen M
    Ann Pharmacother; 2008 Oct; 42(10):1521; author reply 1521. PubMed ID: 18765833
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.